525 related articles for article (PubMed ID: 31498131)
41. The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
Killinger B; Labrie V
J Parkinsons Dis; 2019; 9(s2):S345-S358. PubMed ID: 31609697
[TBL] [Abstract][Full Text] [Related]
42. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?
Vilela C; Araújo B; Soares-Guedes C; Caridade-Silva R; Martins-Macedo J; Teixeira C; Gomes ED; Prudêncio C; Vieira M; Teixeira FG
Cells; 2024 Apr; 13(9):. PubMed ID: 38727306
[TBL] [Abstract][Full Text] [Related]
43. [The role of the gut microbiome in idiopathic Parkinson's disease].
Unger MM; Becker A; Keller A; Schäfer KH; Schwiertz A; Oertel WH
Nervenarzt; 2020 Dec; 91(12):1085-1095. PubMed ID: 33025073
[TBL] [Abstract][Full Text] [Related]
44. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
Pavan S; Prabhu AN; Prasad Gorthi S; Das B; Mutreja A; Shetty V; Ramamurthy T; Ballal M
Folia Microbiol (Praha); 2022 Oct; 67(5):693-706. PubMed ID: 35583791
[TBL] [Abstract][Full Text] [Related]
45. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
[TBL] [Abstract][Full Text] [Related]
46. Gut microbiome in Parkinson's disease: New insights from meta-analysis.
Toh TS; Chong CW; Lim SY; Bowman J; Cirstea M; Lin CH; Chen CC; Appel-Cresswell S; Finlay BB; Tan AH
Parkinsonism Relat Disord; 2022 Jan; 94():1-9. PubMed ID: 34844021
[TBL] [Abstract][Full Text] [Related]
47. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
[TBL] [Abstract][Full Text] [Related]
48. Gut bacterial composition in a mouse model of Parkinson's disease.
Perez-Pardo P; Dodiya HB; Engen PA; Naqib A; Forsyth CB; Green SJ; Garssen J; Keshavarzian A; Kraneveld AD
Benef Microbes; 2018 Sep; 9(5):799-814. PubMed ID: 30099890
[TBL] [Abstract][Full Text] [Related]
49. Microbial treatment: the potential application for Parkinson's disease.
Fang X
Neurol Sci; 2019 Jan; 40(1):51-58. PubMed ID: 30415447
[TBL] [Abstract][Full Text] [Related]
50. Gut dysfunction in Parkinson's disease.
Mukherjee A; Biswas A; Das SK
World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
[TBL] [Abstract][Full Text] [Related]
51. Parkinson's disease and the gastrointestinal microbiome.
Lubomski M; Tan AH; Lim SY; Holmes AJ; Davis RL; Sue CM
J Neurol; 2020 Sep; 267(9):2507-2523. PubMed ID: 31041582
[TBL] [Abstract][Full Text] [Related]
52. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
Rosario D; Bidkhori G; Lee S; Bedarf J; Hildebrand F; Le Chatelier E; Uhlen M; Ehrlich SD; Proctor G; Wüllner U; Mardinoglu A; Shoaie S
Cell Rep; 2021 Mar; 34(9):108807. PubMed ID: 33657381
[TBL] [Abstract][Full Text] [Related]
53. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
54. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
55. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
[TBL] [Abstract][Full Text] [Related]
56. [Correlation Between Emotional-Affective Disorders and Gut Microbiota Composition in Patients with Parkinson’s Disease].
Alifirova VM; Zhukova NG; Zhukova IA; Mironova YS; Petrov VA; Izhboldina OP; Titova MA; Latypova AV; Nikitina MA; Dorofeeva YB; Saltykova IV; Tyakht AV; Kostryukova ES; Sazonov AE
Vestn Ross Akad Med Nauk; 2016; 71(6):427-35. PubMed ID: 29298003
[TBL] [Abstract][Full Text] [Related]
57. Dietary quality and the gut microbiome in early-stage Parkinson's disease patients.
Yoon HJ; Kang W; Jo S; Hwang YS; Lee JH; Chung SJ; Park YK
Nutr Neurosci; 2024 Jul; 27(7):761-769. PubMed ID: 37711026
[TBL] [Abstract][Full Text] [Related]
58. Gut, oral and nasal microbiota and Parkinson's disease.
Shen L
Microb Cell Fact; 2020 Feb; 19(1):50. PubMed ID: 32103766
[TBL] [Abstract][Full Text] [Related]
59. Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis.
Bai F; You L; Lei H; Li X
Exp Gerontol; 2024 Jun; 191():112444. PubMed ID: 38679353
[TBL] [Abstract][Full Text] [Related]
60. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
